Works matching IS 01051873 AND DT 2021 AND VI 84 AND IP 2
Results: 17
Response to: Clinical relevance of p‐tert‐butylphenol‐formaldehyde resin (PTBP‐FR) contact allergy among general dermatology patients.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 2, p. 141, doi. 10.1111/cod.13737
- By:
- Publication type:
- Article
Patch test results with the European baseline series and additions thereof in the ESSCA network, 2015‐2018.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 2, p. 109, doi. 10.1111/cod.13704
- By:
- Publication type:
- Article
Pustular allergic contact dermatitis caused by colophonium in depilatory wax.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 2, p. 130, doi. 10.1111/cod.13695
- By:
- Publication type:
- Article
Tea tree oil contact sensitization in children.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 2, p. 139, doi. 10.1111/cod.13699
- By:
- Publication type:
- Article
Ultrasound assessment of reactive lymphadenopathies due to extreme reactions from patch tests.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 2, p. 136, doi. 10.1111/cod.13698
- By:
- Publication type:
- Article
Rapid response to ciclosporin in patients with Parthenium dermatitis: A preliminary study.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 2, p. 134, doi. 10.1111/cod.13697
- By:
- Publication type:
- Article
Systemic allergic dermatitis caused by a copper‐containing intra‐uterine device.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 2, p. 132, doi. 10.1111/cod.13696
- By:
- Publication type:
- Article
Allergic contact dermatitis due to the liquid skin adhesive Dermabond® predominantly occurs after the first exposure.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 2, p. 103, doi. 10.1111/cod.13700
- By:
- Publication type:
- Article
Allergic contact dermatitis caused by a traditional Chinese medicine treatment— moxibustion.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 2, p. 127, doi. 10.1111/cod.13694
- By:
- Publication type:
- Article
Three cases of non‐atopic hyperkeratotic hand eczema treated with dupilumab.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 2, p. 124, doi. 10.1111/cod.13693
- By:
- Publication type:
- Article
Formaldehyde 2% is not a useful means of detecting allergy to formaldehyde releasers— results of the ESSCA network, 2015‐2018.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 2, p. 95, doi. 10.1111/cod.13691
- By:
- Publication type:
- Article
Developing a cosmetic series: Results from the ESSCA network, 2009‐2018.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 2, p. 82, doi. 10.1111/cod.13690
- By:
- Publication type:
- Article
Anaphylactoid reaction during patch testing for hair dye: A risk of skin testing.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 2, p. 123, doi. 10.1111/cod.13680
- By:
- Publication type:
- Article
Primum non nocere; the importance of evaluating the effect of treatment and considering side effects.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 2, p. 121, doi. 10.1111/cod.13675
- By:
- Publication type:
- Article
Application of the adverse outcome pathway framework for investigating skin sensitization potential of nanomaterials using new approach methods.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 2, p. 67, doi. 10.1111/cod.13669
- By:
- Publication type:
- Article
Contact dermatitis caused by glucose sensors, insulin pumps, and tapes: Results from a 5‐year period.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 2, p. 75, doi. 10.1111/cod.13664
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 2, p. 1, doi. 10.1111/cod.13605
- Publication type:
- Article